Following Moderna's announcement about its COVID-19 vaccination for children, parents around the world have been waiting for any new information concerning its approval by health authorities. The vaccine is currently undergoing testing by Health Canada and will be available to the public in the near future. Moderna was the first pharmaceutical company to apply for vaccine approval from the Canadian government.
The pharmaceutical company registered in late April, according to CTV News, and included the pediatric dose for children aged six months to five years old. In addition, all of Moderna's required pediatric data was received by the US Food and Drug Administration (FDA) for further approval in the United States. According to a representative for Health Canada, the department goes through the review process and priorities it because of the significance of these vaccinations for Canadian families.
Furthermore, he stated that Health Canada will only approve the use of Spikevax in this age category if an independent and thorough high-level scientific review of the provided data proves that the vaccine's benefits far outweigh the disadvantages. The American Academy of Pediatrics tweeted that the Moderna vaccination for children is undergoing a transparent and rapid screening to ensure its efficacy and safety.
Families with children under the age of five have been waiting for this for a long time, as the COVID-19 protocols have been preventing them from living their lives and meddling with their children's daily activities. Only children under the age of five have not yet been vaccinated, as the youngest age group to receive the vaccination is six to eleven years old. Vaccination is, of course, the best way to fight the COVID-19 pandemic, since vaccines are required for children aged 5 and up, boosters for those aged 12 and up, and, as already said, vaccines for younger ages will be available soon.
It's critical to be immune and boosted to resist this coronavirus since new variants can evolve into more contagious strains, putting children in danger of illness and hospitalization. Vaccines for children follow a completely different clinical course from vaccines for adults. Children have a lower chance of adverse effects from COVID 19 infections, according to existing evidence from prior trials. According to studies, the risk of major viral disease rises with age. As a result, the manufacturer's goal is to make the least effective dose available.
In fact, the fifth wave saw the highest number of hospitalizations in Canada among children under the age of five, and as the sixth wave progresses, hospitalizations among this age group are becoming more common, but not in such great numbers. The new strain, sub-variant Omicron BA.2, is distinguishable from the others in that it shows the same symptoms as the others, but with less respiratory distress, vomiting, and diarrhea, as well as a rash that is often mistaken for hand, foot, and mouth disease. While there are no vaccines available for children in this age group, many parental responsibilities should continue to prevent the spread of infection with COVID 19. This involves maintaining a social distance from people, wearing masks indoors, and avoiding crowded places.
Share This Post On
Leave a comment
You need to login to leave a comment. Log-in